Acute Heart Failure (AHF)
25
9
9
4
Key Insights
Highlights
Success Rate
80% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
4.0%
1 terminated out of 25 trials
80.0%
-6.5% vs benchmark
24%
6 trials in Phase 3/4
25%
1 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (25)
Prolonged Nasogastric Administration of Ketones in Decompensated Heart Failure
Sarcopenia in Older Patients Hospitalized for Acute Heart Failure.
Urine Sodium-Driven Diuretic Adjustment Strategy in Acute Decompensated Heart Failure
Pulmonary Embolism in Patients With Acute Heart Failure: A Pragmatic Cluster-Randomized Trial (PEHF Study)
ReDS-guided Decongestion Strategy in Patients Hospitalized for Heart Failure
POcus INTERvention for Tailoring Diuretic Strategy in Acute Decompensated Heart Failure
Evaluating the Effects of Nitroglycerin on Heart Function and Urinary Output in Patients With Acute Heart Failure
Evaluation of Fibroscan® Performance in Diagnosing Acute Heart Failure in Patients Presenting to the Emergency Department
OPTIMUM Study of Remote Patient Monitoring in Ambulatory Heart Failure Care
Restrictive Versus Liberal Fluid Intake in Acute Decompensated Heart Failure
Early Gliflozin for Elderly Patients With Acute Decompensated Heart Failure in the Emergency Department
Digoxin After Acute Heart Failure
Temporary MCS With the iVAC 2L Transaortic Device in High-risk PCI
Simple Urine Composition-based Personalized Algorithm for Effective Congestion Relief in Decompensated Heart Failure
Vietnamese Rapid Acceleration Protocol for Intensifying Drug Therapy in Heart Failure With Reduced Ejection Fraction
Evaluating Residual Congestion at Discharge in Acute Heart Failure Patients
Exogenous KETOne Supplements in Patients Hospitalized for Acute Heart Failure
Electrical Cardiometry in Management of Acute Heart Failure
American Registry of Ambulatory or Acutely Decompensated Heart Failure
Efficacy and Safety of Early Initiation of Vericiguat in Heart Failure After Acute Myocardial Infarction